-
Registrations and welcome coffeeJan. 29
-
S2 - Radiation
Jan. 29
-
S3 - Nursing 1: Sex-Specific Cardiovascular Risk Modifiers - Pregnancy, Menopause, and Aging
Jan. 29
-
S1 - YCC - Invisible Killers: Pollution, Noise & Climate Stress on the Heart?
Jan. 29
-
S4 - Keynote & Gold medal
Jan. 29
-
S5 - Nursing - 2 - Inside the Rhythm: Devices, Leads, and Daily Living
Jan. 29
-
Coffee break & best PosterJan. 29
-
S7 - Scientific symposium sponsored by AstraZeneca: Belgian Initiatives in Cardiovascular Care to improve the journey of patients with heart failure, hypertension, and cardiac amyloidosis
Jan. 29
-
S6 - BACTS & BSC Joint session
Jan. 29
-
S8 - Nursing - 3 - Circulatory Challenges: Managing Pressure, Clotting, and Cerebral Events
Jan. 29
Event BSC congress 2026
starts on
29 Jan 2026, 09:00:00
(Europe/Brussels)
S19 - Scientific symposium sponsored by Eli Lilly - Tirzepatide and the Cardiologist: A New Chapter in Cardiometabolic Risk Management
Symposium
Location: Room Folon
-
30/01/2026, 09:00
-
30/01/2026, 10:15
(Europe/Brussels)
(1 hour 15 minutes)
09:00 – 09:02, Welcome & Opening Remarks
09:02 - 09:27,
Obesity as a Cardiometabolic Catalyst: Mechanisms, Consequences and Therapeutic
Innovation
Roman Vangoitsenhoven,
UZ Leuven
09:27 - 09:47,
Beyond Glycemic Control: Tirzepatide’s potential in Cardiovascular Care for
Type 2 Diabetes
Ann Verhaegen, ZAS
09:47 - 10:02,
Panel Discussion “From Evidence to Action: Incretins in Belgian Cardiometabolic
Practice”
Philippe Van De Borne,
Erasme HUB
Christophe De Block,
UZA
10:02 - 10:12,
Audience Q&A
10:12 - 10:15, min:
Closing Reflections